Table 2.
Coronary angiography (% of cases with the specified disease severity) |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Study, design |
N | Mean study interval, years |
Mean/ median age, years* |
Radiation exposure, Gy (mean) |
≥70% of LAD, LCx, or RCA: |
Ostial vessel ≥50% |
LM≥50% | LM≥70% | |||
1- v | 2- v | 3- v | |||||||||
Orzan et al, 199310 retrospective, observational | Symptomatic | 24 HL/BCA survivors 15 for CAG | 12 | 44 | >45† | 40 | 20 | 13 | 67% | 47% | 43% |
McEniery et al, 19879 retrospective, case–control | 15 HL/BCA survivors 15 for CAG | 16 | 48 | 41 | 53 | 20 | 7 | 27% | 33% | 20% | |
Correa et al, 200746 retrospective, case–control | 46 BCA survivors 13 for CAG | 15 | 55 | 60–65† | 31 | 23 | 0 | NA | NA | NA | |
Heidenreich et al, 200713 prospective, observational | Asymptomatic | 294 HL survivors 40 for CAG | 6.5 | 42 | 44 | 10 | 10 | NA‡ | >28% | NA | 50%‡ |
Rademaker et al, 200847 retrospective, case series | 9 HL survivors 9 for CCTA | 26 | 45 | 40 | 33 | 0 | 0 | 0 | 9% | 9% | |
Daniels et al, 201448 prospective, observational | 48 HL survivors for CCTA 8 for CAG | 21 | 47 | 36 | 33 | 0 | 0 | 33% | 0 | 22% |
Denotes age at time of angiography.
Reported as ‘chest’ or ‘mediastinal dose’; elsewhere, mean heart doses are reported.
Reported as left main≥70% or three-vessel disease with at least one vessel with ≥70% stenosis.
BCA, breast cancer; CAG, coronary angiography; CCTA, coronary CT angiography; LAD, left anterior descending; LCx, left circumflex coronary artery; LM, left main; NA, not available; RCA, right coronary artery.